Brain Imaging: Cocaine Effects & Medication Development - 5

Phase 4

Withdrawn

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000270
• Lead Sponsor: New York State Psychiatric Institute

Brief Summary

The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.

Detailed Description

Not available

Study Timeline

• Study Start: 1995-12-30
• Primary Completion: 1995-12-30
• Study Completion: 1995-12-30
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2017-07
• Last Update Submitted: 2017-08-01
• Last Update Posted: 2017-08-02

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relative change in rCBF at 5, 19, & 33 minutes (O15)
Absolute change in rCBF at 5 & 15 minutes (Xe)
Correlated with a) subjective effects, b) venous blood level of coca, c) autonomic variables

Trial Locations

Locations (1)

New York State Psychiatric Institute; 🇺🇸 New York, New York, United States